Cargando…
The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017
BACKGROUND: Ontario, Canada introduced a publicly-funded 13-valent pneumococcal conjugate vaccine (PCV13) for infants in 2010, replacing the 10-valent (PCV10, 2009–2010) and the 7-valent (PCV7, 2005–2009) conjugate vaccine programs; a 23-valent pneumococcal polysaccharide vaccine (PPV23) has been av...
Autores principales: | Wijayasri, Shinthuja, Hillier, Kelty, Lim, Gillian H., Harris, Tara M., Wilson, Sarah E., Deeks, Shelley L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910703/ https://www.ncbi.nlm.nih.gov/pubmed/31834926 http://dx.doi.org/10.1371/journal.pone.0226353 |
Ejemplares similares
-
West Nile virus illness in Ontario, Canada: 2017
por: Wijayasri, S, et al.
Publicado: (2019) -
Global travel patterns and risk of measles in Ontario and Quebec, Canada: 2007–2011
por: Wilson, Sarah E., et al.
Publicado: (2015) -
The Epidemiology of Invasive Haemophilus influenzae Non-Serotype B Disease in Ontario, Canada from 2004 to 2013
por: Desai, Shalini, et al.
Publicado: (2015) -
1309. Incidence and Epidemiology of Invasive Pneumococcal Disease due to Serotype 3 in South-Central Ontario
por: McGeer, Allison, et al.
Publicado: (2021) -
Epidemiology of serogroup B invasive meningococcal disease in Ontario, Canada, 2000 to 2010
por: Dang, Vica, et al.
Publicado: (2012)